The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

A 2022 study found that within a year of going off semaglutide, sold under the name brands Wegovy and Ozempic, participants regained an average of two-thirds of their lost weight. A ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...